Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China; Institute of Thoracic Oncology, Fudan University, Shanghai, 200032, China.
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Eur J Surg Oncol. 2021 Jul;47(7):1710-1717. doi: 10.1016/j.ejso.2021.01.020. Epub 2021 Jan 30.
To determine the optimal threshold of examined lymph node (ELN) number from cervical lymph node dissection for head and neck squamous cell carcinoma (HNSCC). Further to compare the prognostic value of multiple lymph node classification systems and to determine the most suitable scheme to predict survival.
A total of 20991 HNSCC patients were included. Odds ratios (ORs) for negative-to-positive node stage migration and hazard ratios (HRs) for survival were fitted using the LOWESS smoother. Structural breakpoints were determined by the Chow test. The R square, C-index, likelihood ratio, and Akaike information criterion (AIC) were used to compare the prognostic abilities among AJCC N stage, number of positive lymph nodes (pN), positive lymph node ratio (LNR) and log odds of positive lymph nodes (LODDS) stages.
A minimal threshold ELN number of fifteen had the discriminatory capacities for both stage migration and survival. LODDS stages had the highest R square value (0.208), C-index (0.736) and likelihood ratio (2467) and the smallest AIC value (65874). LODDS stages also showed prognostic value in estimating patients with AJCC N0 stage. A novel staging system was proposed and showed good prognostic performance when stratified by different primary sites.
Fifteen lymph nodes should be examined for HNSCC patients. LODDS stage allows better prognostic stratification, especially in N0 stage. The proposed staging system may serve as precise evaluation tools to estimate postoperative prognoses.
确定头颈部鳞状细胞癌(HNSCC)颈淋巴结清扫术检查的最佳淋巴结(ELN)数目阈值。进一步比较多种淋巴结分类系统的预后价值,并确定预测生存的最合适方案。
共纳入 20991 例 HNSCC 患者。使用 LOWESS 平滑法拟合阴性至阳性淋巴结分期迁移的优势比(OR)和生存的风险比(HR)。通过 Chow 检验确定结构断点。使用 R 平方、C 指数、似然比和赤池信息量准则(AIC)比较 AJCC N 分期、阳性淋巴结数(pN)、阳性淋巴结比(LNR)和阳性淋巴结对数比值(LODDS)分期的预后能力。
最小的 ELN 数量阈值为 15 个,具有分期迁移和生存的区分能力。LODDS 分期具有最高的 R 平方值(0.208)、C 指数(0.736)和似然比(2467),以及最小的 AIC 值(65874)。LODDS 分期在估计 AJCC N0 分期患者的预后方面也具有价值。提出了一种新的分期系统,在按不同原发部位分层时显示出良好的预后性能。
HNSCC 患者应检查 15 个淋巴结。LODDS 分期可更好地进行预后分层,尤其是在 N0 期。所提出的分期系统可作为评估术后预后的精确评估工具。